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SUMMARY
The RING domain proteins BRCA1 and BARD1
comprise a heterodimeric ubiquitin (E3) ligase that
is required for the accumulation of ubiquitin conju-
gates at sites of DNA damage and for silencing at
DNA satellite repeat regions. Despite its links to
chromatin, the substrate and underlying function of
the BRCA1/BARD1 ubiquitin ligase remain unclear.
Here, we show that BRCA1/BARD1 specifically ubiq-
uitylates histone H2A in its C-terminal tail on ly-
sines 127 and 129 in vitro and in vivo. The specificity
for K127-129 is acquired only when H2A is within a
nucleosomal context. Moreover, site-specific target-
ing of the BRCA1/BARD1 RING domains to chro-
matin is sufficient for H2Aub foci formation in vivo.
Our data establish BRCA1/BARD1 as a histone-
H2A-specific E3 ligase, helping to explain its localiza-
tion and activities on chromatin in cells.
INTRODUCTION
Breast cancer-associated protein 1 (BRCA1) is a key mediator
in the DNA damage response, which is linked to a wide range
of functions that serve to maintain genomic stability. Cellular
BRCA1 forms a heterodimer with BRCA1-associated RING
domain 1 (BARD1) (Wu et al., 1996), which promotes the repair
of double-stranded DNA breaks through homologous recombi-
nation (Moynahan and Jasin, 2010) and contributes to the
DNA-damage-induced G2/M checkpoint (Xu et al., 2001). Loss
of BRCA1 function in cells results in hypersensitivity to DNA
damage and accumulation of chromosomal aberrations associ-
ated with the development of cancer (Venkitaraman, 2001).
In vitro studies have shown that the RING domains of BRCA1/
BARD1 possess a ubiquitin ligase (E3) function (Ruffner et al.,
2001), but a bona fide substrate for this activity is still lacking.
During replication and after treatment with agents that damage
DNA, BRCA1 and BARD1 colocalize in discreet nuclear foci
with ubiquitin conjugates (Morris and Solomon, 2004). However,
it is not known whether these conjugates are a product of
BRCA1/BARD1 E3 activity or arise through the function of
several other E3 proteins that also colocalize at sites of DNA
double-strand breaks as part of a ubiquitin-mediated DNA-dam-
age-signaling pathway (Doil et al., 2009; Mattiroli et al., 2012;
Stewart et al., 2009).
Recently, Zhu et al. (2011) reported that defects in BRCA1
E3 function are linked with a derepression of satellite DNA that
is accompanied by decompaction of chromatin and reduced
levels of ubiquitylated histone H2A (H2Aub). Moreover, these
phenotypes can be reversed by exogenous expression of his-
tone H2A protein fused to ubiquitin. However, a direct role for
BRCA1/BARD1-dependent ubiquitylation of histones was not
established.
We investigated the interaction of BRCA1/BARD1 with chro-
matin and found that it involves a highly specific histone H2A-
ubiquitin ligase that modifies previously uncharacterized lysines
in the C-terminal tail of H2A. We discuss these observations in
light of the known biological functions of BRCA1.
RESULTS
BRCA1/BARD1 Ubiquitylates H2A in Nucleosomes
Although BRCA1 binds to DNA in a sequence-independent
manner in vitro (Paull et al., 2001), in cells, it is most commonly
found at DNA breaks associated with chromatin. Accordingly,
we found that purified recombinant BRCA1/BARD1 bound
nucleosome substrates in an electrophoretic mobility shift assay
(EMSA) (Figures S1A–S1F). The binding was dynamic, as com-
plexes were competed away by addition of unlabeled DNA
(Figure S1D). This binding, along with the known structural
similarities between the RING domains of BRCA1/BARD1 and
those of the histone-H2A-specific ubiquitin ligase complex Poly-
comb repressive complex 1 (PRC1) (Buchwald et al., 2006; Fig-
ure S1G), prompted us to investigate whether BRCA1/BARD1
ubiquitylates nucleosomal histone proteins.
We examined BRCA1/BARD1 E3 activity on individual his-
tone proteins and reconstituted nucleosome substrates in vitro
and compared it with the activity of the RING1B/MEL-18 sub-
units of PRC1 (Figures 1A and 1B). As reported previously,
RING1B/MEL18 monoubiquitylated individual histone proteins
with similar efficiency in vitro, but ubiquitylated nucleosome sub-
strates specifically on K118-119 of H2A (Figure 1A). This reflects
the known cellular specificity of PRC1 for K118-119 of H2A
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(Elderkin et al., 2007; Wang et al., 2004). BRCA1/BARD1 acted
similarly, ubiquitylating individual H2A, H2B, H3, and H4 proteins
in vitro without any apparent preference (Mallery et al., 2002; Fig-
ure 1B). However, when BRCA1/BARD1 was incubated with re-
combinant nucleosomes or native chromatin, only H2A was
ubiquitylated (Figure 1B). We concluded that BRCA1/BARD1
E3 activity resembles that of PRC1 in that it acquires specificity
for histone H2A as a substrate when the latter is incorporated
into nucleosomes.
BRCA1/BARD1 RING Domains Ubiquitylate H2A In Vivo
The recruitment of BRCA1/BARD1 to sites of DNA damage is
dependent on the activity of several other E3 ligases that ubiq-
uitylate histone H2A. To establish that BRCA1/BARD1 can ubiq-
uitylate chromatin in cells independently of these confounding
activities, we took advantage of the fact that its E3 function re-
sides within a small region encompassing the RING domains of
each protein. We developed an assay to measure the potential
of the BRCA1/BARD1 heterodimeric RING complex, which was
previously shown to adopt the same structure and have the
same biochemical activity as the full-length BRCA1/BARD1
RING complex (Christensen et al., 2007), to ubiquitylate histone
H2A at a defined site in the genome of U2OS 2-6-3 cells inde-
pendently of its association with other proteins. The BARD1
RING (residues 26–126)-Gly2SerGly2-BRCA1 RING (residues
2–109) fusion protein (hereafter referred to as BDfBC) was fused
to mCherry and Lac Repressor (LacI) sequences and trans-
fected into U2OS 2-6-3 cells containing 200 copies of a trans-
gene with a 256 3 lac operator sequence (lacO) integrated at
a single locus in the genome. Expression of BDfBC-mCherry-
LacI in 2-6-3 cells coincided with the appearance of a single
predominant mCherry nuclear focus that colocalized with conju-
gated ubiquitin (using FK2 antibody) or H2Aub (using E6C5
antibody; Figures 2A, 2B, and S2A), or after transfection of ubiq-
uitin-GFP (data not shown). Recruitment of BDfBC also coin-
cided with increased accumulation of H2Aub at the same site
(Figures 2C, 2D, and S2B). Full-length BRCA1 protein, in which
isoleucine 26 of its RING domain was mutated to alanine, is
defective in E3 ligase activity in vitro (Figure S3A). Accordingly,
site-specific H2Aub was not observed after expression of the
‘‘E3-ligase-dead’’ mutant BDfBCI26A-mCherry-LacI in vivo (Fig-
ures 2C and 2D). We concluded that the BRCA1/BARD1 RING
domain complex can specifically ubiquitylate chromatin-associ-
ated H2A in vivo.
BRCA1/BARD1 Ubiquitylates H2A at a Novel Site In Vitro
and In Vivo
Next, wewished to identify the lysine residue on histone H2A that
is modified by BRCA1/BARD1. Recently, RNF168 was shown to
monoubiquitylate the N-terminal tail of histone H2A on lysines
K13-15 (Mattiroli et al., 2012). However, this was not the case
for BRCA1/BARD1, which efficiently ubiquitylated nucleosomes
reconstituted with H2A deleted for its N-terminal tail (Figures
S3B and S3C). In contrast, RING1B/MEL18 ubiquitylates histone
H2A predominantly at lysine 119 in its C-terminal tail both in vitro
and in vivo (Elderkin et al., 2007).
We tested recombinant Xenopus laevis nucleosomes con-
taining H2A mutated in different lysines at its C-terminal tail.
Whereas RING1B/MEL18 did not ubiquitylate nucleosomes re-
constituted with mutant H2A K118-119R protein in vitro (Fig-
ure 3A; Elderkin et al., 2007), these same mutant nucleosomes
were efficiently ubiquitylated by BRCA1/BARD1 (Figure 3B),
indicating that it could modify residues other than K118 and
K119. However, BRCA1-dependent ubiquitylation wasmarkedly
reduced with nucleosomes in which both K124 and K127 of
H2A were mutated to arginine (H2A K124-127R) (Figure 3B).
Ubiquitylation was further reduced in an H2A K124-127-129R
mutant, suggesting that BRCA1/BARD1 ubiquitylates histone
H2A in vitro at one or more of three residues (K124, K127, and
K129). A direct comparison of H2Aub generated by RING1B/
MEL18 and that produced by BRCA1/BARD1 in vitro revealed
a small difference inmigration after SDS-PAGE, providing further
evidence that H2Aub produced by BRCA1/BARD1 in vitro
occurred at a different lysine residue (Figure 3C).
To determine which of the lysines in the H2A C-terminal tail is
the preferred site of ubiquitin conjugation by BRCA1/BARD1, we
ubiquitylated chromatin purified from chicken erythrocytes
in vitro and analyzed the products by mass spectrometry. We
were able to identify ubiquitylation of the C-terminal peptide
KAK (residues 126–128 of chicken H2A; Figures 3G, top, and
S3E). Coupled with the detection of unmodified lysine 128, this
suggested that K126 of chicken H2A (equivalent to K127 in Xen-
opus and human) might be the predominant residue for BRCA1/
BARD1-dependent ubiquitin conjugation in vitro.
BRCA1/BARD1 Ubiquitylates Human Histone H2A at
K127 and K129 In Vivo
The most abundant form of H2A ubiquitylation in cells is K118-
119. To determine the specific lysine in histone H2A that is ubiq-
uitylated by BRCA1/BARD1 in vivo, we used DT40 cells stably
expressing wild-type or mutant forms of FLAG-H2A. FLAG-
H2A protein was immunoprecipitated with anti-FLAG, and west-
ern blots were probed with antibodies against H2Aub (E6C5),
H
2A
H
2B
H
3
H
4
X
l.N
uc
C
hr
om
at
in
RING1B/
MEL18
A B
125I-ub
*125I-ubhistones
BRCA1/
BARD1
*
125I-ub
125I-ub
histones
H
2A
H
2B
H
3
H
4
X
l.N
uc
C
hr
om
at
in
Figure 1. BRCA1/BARD1 Specifically Ubiquitylates Histone H2A
in Nucleosomes
(A and B) Ubiquitylation of recombinant Xenopus laevis histones (H2A, H2B,
H3, and H4), reconstituted nucleosomes, and chromatin isolated from HeLa
cells by RING1B/MEL18 (A) or BRCA1/BARD1 (B) ubiquitin ligases.
125I-labeled ubiquitin is covalently linked to its substrate and detected after
SDS-PAGE. Specificity for a single histone occurs only within a nucleosomal
context. Small amounts of diubiquitylated histone were observed as indicated
(*). See also Figure S1.
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ubiquitin (FK2), or FLAG epitope (Figure 3D). This confirmed
that mutant FLAG-H2A K118-119R was ubiquitylated, albeit at
a greatly diminished level compared with wild-type H2A. Ubiqui-
tylation was further reduced in cells expressing FLAG-H2A
K118-119-125-127-129R, confirming ubiquitylation of H2A at
its C-terminal tail in vivo (Figure 3D).
We next expressed the separate BRCA1 and BARD1 RING
domains (BC-R/BD-R) in DT40 cells with different mutant
FLAG-H2A proteins. In untransfected cells expressing wild-
type FLAG-H2A, western blots revealed a single band corre-
sponding to H2AubK119 (band 1; Figure 3E). Upon transfection
with BC-R/BD-R, we observed a second, slower-migrating band
(band 2) similar to that observed after ubiquitylation of H2A
by BRCA1/BARD1 in vitro. Whereas band 1 was absent in cells
expressing mutant FLAG-H2A K118-119R, band 2 was induced
upon expression of BC-R/BD-R in these cells. Band 2 was
not observed in cells expressing FLAG-H2A K124-127-129R
mutant, suggesting that ubiquitylation required one or more of
the three most C-terminal lysine residues of H2A. We observed
a similar requirement for K125, K127, and K129 for ubiquitylation
of FLAG-H2A K118-119R in HEK293 cells expressing the BDfBC
RING domain complex (Figure S3D). Although these data high-
light the importance of K127 for ubiquitylation of H2A, they did
not establish which of the lysine residues (K125, K127, and
K129) becomes conjugated to ubiquitin.
Given that H2Aub comprises only 5%–10% of all H2A in cells,
the amount of H2Aub that was modified at lysine residues other
than K118-119 was extremely low (Figures 3D and 3F). Expres-
sion of the RING fusion protein BDfBC in HEK293 cells signifi-
cantly increased the cellular pool of H2Aub, indicating that
H2A is an efficient substrate for this E3 even when it is not
specifically directed to chromatin as a fusion protein with LacI
(Figure 3F). By contrast, we observed no increase in H2Bub after
expression of BDfBC (Figure S2B). Next, we purified chromatin-
associated H2Aub from cells expressing BDfBC and analyzed it
by mass spectrometry. The number and close proximity of lysine
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Figure 2. Ubiquitylation of Histone H2A by BRCA1/BARD1 E3 Activity In Vivo
(A and C) Site-specific recruitment of the BRCA1/BARD1 E3 to a single genomic location in HEK293 2-6-3 cells results in ubiquitylation of histone H2A. U2OS 2-6-
3 cells containing 200 tandem copies of a 256 LacO sequence integrated at a specific site were transiently transfected with plasmids expressing mCherryLacI,
BDfBC-mCherryLacI, or mutant BDfBC-I26A-mCherryLacI.
(A and B) Cells were stained with antibodies against H2Aub (E6C5; A) and scored for colocalization with mCherry (B).
(C and D) Cells were stained with antibodies against ubiquitin (FK2; C) and scored for colocalization with mCherry (D).
Representative images are shown. Values represent the mean from two independent experiments (n = 100). Error bars represent 1 SD. Scale bar represents
10 mm. See also Figure S2.
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residues required us to digest H2Aubwith pepsin at pH 1.3 rather
than trypsin prior to mass spectrometry analysis. We found that
although the majority of cellular H2Aub was modified on K118 or
K119, expression of BDfBC coincided with the recovery of ubiq-
uitylated peptide corresponding to the C-terminal residues GK
(residues 128-129) of H2A (Figures 3G, bottom, and S3F). We
also identified peptides consistent with low-level ubiquitin conju-
gation at K127 (Figure S3G). On the basis of these data, the pri-
mary acceptor for BRCA1 E3 activity is probably lysine 129 of
histone H2A. However, lysine 127, which is important for efficient
ubiquitylation of H2A by BRCA1/BARD1 in vitro and in vivo, may
also be ubiquitylated.
DISCUSSION
To date, neither the substrate nor the function of the BRCA1/
BARD1 ubiquitin ligase has been well established. We have es-
tablished that BRCA1/BARD1 specifically ubiquitylates histone
H2A in chromatin in vitro and in vivo. Our data support a role
for BRCA1/BARD1 as a histone-H2A-specific ubiquitin ligase
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Figure 3. BRCA1/BARD1 Ubiquitylates
K127-129 of Histone H2A In Vitro and In Vivo
(A) Ubiquitylation of nucleosomes by RING1B/
MEL18 is impaired by mutation of lysines 118 and
119 of histone H2A.
(B) Ubiquitylation of nucleosomes by BRCA1/
BARD1 is reduced for histone H2A mutated at
lysines K124, K127, and K129. Small amounts
of diubiquitylated histone were observed as
indicated (*).
(C) Ubiquitylation of recombinant Xenopus nucle-
osomes by BRCA1/BARD1 and RING1B/MEL18,
showing the difference in migration of the H2Aub
product.
(D) FLAG-H2A was stably expressed in DT40 cells
and immunoprecipitated under denaturing condi-
tions as described previously (Wang et al., 2004).
Cells expressing wild-type or mutant H2A are
indicated. Immunoprecipitated proteins were
analyzed by western blot and probed with anti-
bodies against FLAG, ubiquitin (FK2), and ubiq-
uityl-H2A (E6C5).
(E) DT40 cell lines expressing wild-type or mutant
FLAG-H2A (K118/119R, K124/127/129, and K118/
119/124/127/129) were transfected with the RING
domains of BRCA1 and BARD1. Cells were har-
vestedafter48hrandhistoneproteinswere isolated
by acid extraction. FLAG-H2Aub was detected by
western blot with anti-FLAG after separation by
PAGE. H2Aub was detected after expression of
the BRCA1 and BARD1 RING domains (band 1)
and/or by endogenous E3 activity (band 2).
(F) HEK293 cells expressing BDfBC-EGFP-NLS
protein under the control of a Tet-responsive
promoter was induced overnight with 1 mg/ml
doxycycline. Nuclei were prepared from the cells
and acid-extracted histones were separated on a
12% BisTris Novex gel and probed with the indi-
cated antibodies. Increased H2Aub dependent on
expression of BDfBC is indicated for two indepen-
dent clones (#8 and #1).
(G) Top, BRCA1/BARD1 ubiquitylates chicken
histone H2A at lysine 126 (equivalent to K127 in
humans) in nucleosomes. The modified peptide
fragments identified by mass spectrometry are
indicated. Data supporting this modification are
provided in Figure S3E. Bottom, BDfBC expressed
in HEK293 cells ubiquitylates human histone H2A
at lysine K127-129. H2Aub was recovered from
chromatin as described in the Experimental Pro-
cedures. Themodified peptide fragments identified
by mass spectrometry are indicated in the illustra-
tion. Data supporting this modification are provided
in Figure S3F.
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that ubiquitylates the C-terminal tail of H2A at the previously
uncharacterized lysine residues K127-129.
Several pieces of evidence link BRCA1-dependent E3 activ-
ity with ubiquitylation of histones in chromatin. First, purified
BRCA1/BARD1 ubiquitylates individual histone proteins in vitro,
albeit with little specificity (Chen et al., 2002; Hashizume et al.,
2001; Mallery et al., 2002). We show that the specificity of
BRCA1/BARD1 for K127-129 of H2A is acquired only in a nucle-
osomal context, a characteristic that is shared with RING1B/
MEL18 for ubiquitylation of H2Aub118-119 (Elderkin et al.,
2007). Moreover, our data suggest that the ability to discriminate
nucleosome substrate from free histone in vivo resides within the
heterodimeric RING domains comprising amino acids 1–109 of
BRCA1 and 1–126 of BARD1.
Second, the RING domains of BRCA1/BARD1 that confer its
E3 activity are structurally related to the RING1B/MEL18 RING
domain subunits of the histone-H2A-specific ubiquitin ligase
PRC1 (Brzovic et al., 2006; Buchwald et al., 2006; Li et al.,
2006). Of note, the basic patches on the surface of RING1B/
BMI1, which have been shown to be involved in DNA binding
of the E3-UbcH5 complex on nucleosomes (Bentley et al.,
2011), are conserved in BRCA1, but not in BARD1. However, it
is unclear whether this might affect the position of E3 relative
to its nucleosome substrate.
We note that BRCA1/BARD1 and RING1B/MEL18 are hetero-
dimeric E3 ligases (Brzovic et al., 2001; Buchwald et al., 2006; Li
et al., 2006), whereas RNF168 is monomeric (Campbell et al.,
2012) and therefore might interact with its chromatin substrate
in a different manner (Mattiroli et al., 2012). Recent evidence sug-
gests that ubiquitylation of histone H2A by RING1B/BMI1 and
RNF168 is dependent on an acidic patch present on the exposed
surface of nucleosomes. Expression of a peptide that interfered
with binding to this acidic patch caused a reduction in DNA-
damage-induced H2Aub by RNF168 and a concomitant failure
to recruit BRCA1 at sites of DNA damage in vivo (Leung et al.,
2014; Mattiroli et al., 2014). However, recruitment of BRCA1 at
sites of DNA damage is dependent on RNF168-mediated ubiqui-
tylation, and therefore no conclusion can be made regarding the
effect on BRCA1 E3 ligase activity.
Third, our data support recent evidence indicating that small
interfering RNA (siRNA)-mediated knockdown of BRCA1 results
in derepression of satellite DNA with an accompanying loss of
H2Aub in this region (Zhu et al., 2011). Our findings highlight
the potential for BRCA1 to function directly in this process
through ubiquitylation of histone H2A. This is consistent with
the demonstration by Zhu et al. (2011) that repression of satellite
DNA can be restored by expression of histone H2A protein fused
at its C terminus with ubiquitin. Moreover, it suggests that
although ubiquitylation of H2A on K127-129 is characteristic of
BRCA1/BARD1 E3 function, the exact position of this ubiquitin
in the C-terminal tail might not be critical for its role in repression
of satellite DNA. It is possible that H2AubK127-129 and themore
common H2Aub119 perform very similar functions in chromatin,
and that BRCA1/BARD1 targets this modification to specific re-
gions of chromatin.
BRCA1 has been linked to ubiquitin conjugates on chromatin
at sites of DNA breaks. However, previous attempts to visualize
the ubiquitylated products of BRCA1/BARD1 E3 activity at sites
of DNAdamage have been hampered by its complex recruitment
to sites of DNA breaks involving a ubiquitin-mediated signaling
pathway and several different ubiquitin ligases (Gospodinov
and Herceg, 2013). Here, we show that site-specific targeting
of the BRCA1/BARD1 RING domains is sufficient for local ubiq-
uitylation of H2A in vivo. Mass spectrometry analysis confirmed
that the biochemical activity and specificity of the BDfBC
complex to ubiquitylate the C-terminal tail of H2A on lysines
K127-129 in vivo reflect those of the full-length BRCA1/BARD1
complex in vitro. Moreover, using the ‘‘E3-dead’’ I26A mutant
protein, we established that generation of H2Aub by BDfBC is
specifically dependent on BRCA1 E3 activity.
Previous studies led us to believe that the position of ubiquitin
within a nucleosome is more important for its function than the
exact location of the modification within the histone tail. Indeed,
it has been shown that ubiquitin fused to the very C-terminal
amino acid of histone H2A contributes to the repression of
satellite DNA. The exact role(s) of ubiquitin, however, is still
enigmatic.
The contribution of BRCA1 E3 activity to the DNA damage
response is unclear. Mice expressing the enzymatically dead
mutant BRCA1(I26A) are no more tumor prone than those ex-
pressing wild-type protein (Shakya et al., 2011). On the other
hand, murine embryonic stem cells expressing this BRCA1
I26A mutant protein have increased levels of genomic aberra-
tions (Reid et al., 2008). It is possible that rather than promoting
repair, the BRCA1 ubiquitin ligase functions as a negative regu-
lator of double-strand break repair, as was shown recently for
the ubiquitin-binding RAP80 complex (Coleman and Greenberg,
2011).
Although the role of monoubiquitylated H2A at DNA breaks is
still unclear, our data establish the potential of BRCA1/BARD1 as
a specific H2A ubiquitin ligase on nucleosome substrates. More-
over, the identification of a previously uncharacterized form of
H2Aub that might be uniquely associated with the E3 activity
of BRCA1 raises the possibility of generating antibodies directed
against H2AubK127-129 for use as a diagnostic tool to identify
biochemically active BRCA1.
EXPERIMENTAL PROCEDURES
Cell Culture
DT40 chicken cells were propagated in standard media supplemented with
RPMI (Invitrogen) at 37C, 6% CO2. HeLa cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM; Invitrogen) supplemented with 10% fetal
calf serum. HEK293 FlpIn T-Rex cells (Invitrogen) were grown in DMEM con-
taining 10% tetracycline-free fetal bovine serum.
Microscopy
Cells were prepared as described in the Supplemental Experimental Proce-
dures and visualized using an LSM510 confocal microscope (Leica).
Ubiquitylation of Recombinant Nucleosomes and Chromatin
Recombinant X. laevis histones were expressed and purified from E. coli
and reconstituted into nucleosomes as described in the Supplemental Exper-
imental Procedures. The chicken histone octamers were a kind gift from Pro-
fessor Daniela Rhodes and were purified from chicken erythrocyte nuclei as
described previously (Thomas and Butler, 1980). For nucleosome ubiquityla-
tion, chromatin or individual histones were incubated with 200 ng E1 (affinity
or Boston Biochem), 200 ng UbcH5c (affinity or Boston Biochem), 1 mg
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ubiquitin (Sigma), 1mMATP and 0.1 mg purified E3were in a reaction volumeof
10 ml for 15 min, followed by addition of 10 ml of 0.5 mg 125I-ubiquitin, substrate
and 1 mM in 1x ub buffer (Mallery et al., 2002). Reactions were stopped by
addition of SDS buffer and applied for gel electrophoresis.
Purification of Ubiquitylated Histones and Mass Spectrometry
H2Aubwas isolated from cells by initial purification of H2A and H2B from chro-
matin in cells using the Histone Purification Kit (Active Motif). Histones were
separated by PAGE using 12% Bis-Tris gel (Invitrogen) and MES buffer, and
Coomassie-stained H2Aub bands were excised. In-gel digestion with pepsin
(pH 1.3) was performed and peptides were analyzed by nanoLC-LTQ/Orbitrap
in a data-dependent tandem mass spectrometry mode. For nucleosomes
ubiquitylated in vitro, in-gel digestion was also performed with pepsin and
analyzed by NextGen Bioscience.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2014.07.025.
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